Recent Articles from Investor Brand Network

For decades, a cannabis conviction from 1980 trailed Roosevelt Myles, lingering on his record long after he served his time. Myles, an Illinois resident, spent nearly three decades behind bars for a murder he maintained he did not commit. An appellate court later overturned the conviction, and a judge granted him a certificate of innocence after finding no physical evidence connected him to the crime.

WeShop Holdings (NASDAQ: WSHP) announced expanded access to leading health and fitness brands through its community-owned social commerce marketplace, including adidas AG (XETRA: ADS), Under Armour Inc. (NYSE: UAA, UA), NIKE Inc. (NYSE: NKE), ASICS Corp. (OTC: ASCCF) and GNC Holdings. Available immediately within the WeShop app, the curated selection spans performance apparel, footwear, supplements and recovery products, integrating the company’s ShareBack(TM) rewards model so qualifying purchases contribute toward potential equity participation. The company said the initiative is designed to support sustained wellness engagement beyond seasonal resolutions, citing research showing most fitness goals are abandoned within the first six weeks of the year.

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) announced submission of its final reporting under Phase 1 of its Other Transaction Agreement with the US Department of War to the US Army Contracting Command – Orlando, including a Final Demonstration Report and Techno-Economic Analysis for work completed at its RapidSX(TM) Commercialization and Demonstration Facility. The report detailed approximately 6,000 hours of simulated commercial operation and more than 10,000 recovery and purity comparison points, demonstrating that Ucore’s proprietary RapidSX(TM) platform efficiently executed solvent extraction chemistry and produced thousands of liters of rare earth chloride products, supporting its scalability and capital efficiency compared with conventional solvent extraction methods.

Gaxos.ai (NASDAQ: GXAI) announced it has finalized an agreement with BytePlus, the enterprise technology division of ByteDance, securing preferred pricing and early access to advanced AI video generation models to enhance its Art-Gen image and video creation platform. The company said the partnership is expected to reduce infrastructure costs, improve scalability and strengthen gross margins as adoption grows, while accelerating monetization through subscription and credit-based tiers and supporting expansion within the global creator economy.

Alibaba recently introduced a new AI system aimed at advancing robotics, signaling the company’s growing ambitions in a sector attracting intense global interest.

The European Union has accused TikTok of designing its platform in a way that encourages addiction, especially among young users. EU officials say the popular video-sharing app is not doing enough to protect minors from spending too much time online. As a result, regulators are demanding changes to how the platform works in Europe.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

FingerMotion (NASDAQ: FNGR) announced it has entered into a non-binding memorandum of understanding with Digital Landia Ltd. to evaluate development of a minimum viable product and B2C marketplace initiative for North America leveraging artificial intelligence and blockchain architecture. The parties will assess integration of Digital Landia’s proposed protocol framework with FingerMotion’s mobility data infrastructure, including monetization strategy design and MVP performance validation, with plans to complete due diligence and potentially negotiate a definitive cooperation agreement within 60 days, subject to regulatory and commercial feasibility.

Earth Science Tech (OTC: ETST) announced a series of strategic initiatives aimed at enhancing transparency, governance and alignment with long-term shareholder value as it advances toward becoming a fully institutional-ready public company. Building on approximately $3.3 million in net income for fiscal 2025 and anticipated $1.4 million in cost savings in fiscal 2026, the company outlined plans to optimize its portfolio through potential divestitures and brand consolidation, introduce advisory shareholder votes on executive compensation and Series B Preferred Stock retirement, rationalize its capital structure and reduce executive and board compensation, as management positions the company for disciplined growth and improved operating leverage.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

Renewal Fuels (OTC: RNWF) announced that Travis Yakimishyn, P.Eng., has joined the company as chief electrical and power systems officer, where he will oversee electrical architecture and grid integration strategy for Kepler’s Texatron(TM) aneutronic fusion platform. Yakimishyn brings experience in grid interconnection, substation design, high-voltage systems and utility-scale infrastructure, and will advance scalable electrical design standards and interconnection pathways as development moves toward commercialization. The company also said it continues to progress additional patent filings for Texatron and regulatory initiatives, including Form 10 preparation, audit completion and corporate actions tied to its transition to American Fusion.

Earth Science Tech (OTC: ETST) announced it has engaged Semple, Marchal & Cooper LLP as its new independent Public Company Accounting Oversight Board auditor, citing the need to strengthen its financial governance framework as operations expand across pharmacy compounding, telemedicine and real estate. The board determined that the firm’s broader resources and multidisciplinary expertise align with the company’s growing operational complexity, supporting enhanced auditing efficiencies and oversight as ETST continues scaling its diversified health and wellness portfolio.

Forward Industries (NASDAQ: FWDI), a SOL treasury company, recently reported the company’s fiscal first quarter 2026 financial and operating results

NRx Pharmaceuticals (NASDAQ: NRXP) announced completion of an in-person Type C guidance meeting with the U.S. Food and Drug Administration, attended by leadership from the Division of Psychiatry Products, Office of Neuroscience and Center for Drug Evaluation and Research. Based on oral guidance, the company believes it has a path to file a New Drug Application for NRX-100, a preservative-free ketamine formulation, supported by existing adequate and well-controlled trials and confirmatory evidence from more than 65,000 patients in a Real World Evidence dataset, while also seeking a broader indication for treatment-resistant depression with suicidality. The FDA advised that no additional nonclinical or bridging studies would be required, and the company said it will work with the agency to finalize a statistical analysis protocol, with further details to follow upon receipt of formal meeting minutes.

Earth Science Tech (OTC: ETST) reported financial and operational results for the third fiscal quarter ended Dec. 31, 2025, with revenue of $8.4 million, up 14.1% year over year, gross profit of $6.4 million reflecting a 76.3% margin, and net income of $910,000, up 341% from the prior-year period. Adjusted EBITDA totaled $1.2 million, total assets increased to $8.1 million, and the company repurchased and retired 3.7 million shares during the first nine months of fiscal 2026, while ending the quarter with $416,000 in cash, $773,000 in working capital and no bank debt as management cited continued operating leverage and expansion initiatives heading into calendar 2026.

CNS Pharmaceuticals (NASDAQ: CNSP) announced that recently appointed President and CEO Rami Levin, in alignment with the board, has recruited Steven O’Loughlin as chief financial officer, Eric Faulkner as chief technology officer and Dylan Wenke as chief business officer, effective March 2, 2026. The company said the appointments support its strategic evolution following a comprehensive review of its pipeline and capital allocation priorities, positioning CNS Pharmaceuticals to advance development programs with a focus on disciplined growth, operational execution and long-term value creation in treatments for brain and central nervous system cancers.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Earth Science Tech (OTC: ETST) was featured on the latest episode of The BioMedWire Podcast released by IBN, with Chairman and CEO Giorgio R. Saumat outlining the company’s vertically integrated healthcare model spanning telehealth and compounding pharmaceuticals, its cash-flow-positive operations and strong balance sheet, and preparations for a potential uplist. During the interview, Saumat highlighted the company’s profitability, limited debt and 2025 diversification initiatives, as Earth Science Tech positions to scale operations in 2026 while IBN continues expanding its specialized content distribution platform.

Globavend Holdings (NASDAQ: GVH) reported financial results for the year ended Sept. 30, 2025, with revenue rising 42.5% year over year to $23.6 million. The company said it handled an average of 10,394 packages per day, up 69.4% from the prior year, while average daily revenue per freight weight increased 12.7%. Net income totaled $0.68 million. During the year, Globavend established a subsidiary in China and built out corporate infrastructure to support expansion, as management cited capital markets support and a growing pipeline positioning the company for continued revenue growth into 2026 and beyond.

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising.

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

Wearable Devices (NASDAQ: WLDS) announced the upcoming launch of Mudra Experience Studio, a developer platform designed to standardize neural gesture input across extended reality, mobile and AI-powered applications. The platform will offer production-ready SDKs, a unified gesture taxonomy and OEM integration tiers to enable cross-platform deployment without platform-specific rebuilding, positioning the company to expand from a hardware-focused innovator to a full-stack platform provider, while supporting its 2026 rollout through a priority waitlist and recent leadership expansion within its ai6 Labs division.

Telomir Pharmaceuticals (NASDAQ: TELO) announced new in vitro data showing that Telomir-1 (Telomir-Zn) induced broad tumor cell mortality across biologically distinct subtypes of triple-negative breast cancer, with iron-rescue experiments confirming the effect is iron-dependent and linked to the drug’s proposed intracellular metal-modulating mechanism. The company said supplemental iron significantly attenuated tumor cell mortality, supporting that Telomir-Zn reduces labile redox-active iron while increasing zinc availability, targeting the elevated iron levels and oxidative stress observed in many triple-negative breast cancer tumors.

Nutriband (NASDAQ: NTRB) announced it has entered into an exclusive distribution agreement with Costa Rica-based Innomedica for AVERSA Fentanyl, upon approval, and all sports tape products manufactured at its Pocono Pharmaceutical/Active Intell subsidiary. Under the agreement, Innomedica will oversee and finance regulatory approvals as the products advance toward launch. Nutriband’s AVERSA abuse-deterrent transdermal technology is designed to incorporate aversive agents into patches to deter abuse, diversion and misuse of drugs with abuse potential, supported by a broad international patent portfolio.

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising.

The global appetite for more intuitive, seamless interaction with technology is accelerating, and AI-powered, touchless sensing wearables are emerging as a cornerstone of this transformation. Wearable Devices (NASDAQ: WLDS) is at the forefront of this trend, leveraging neural-input interfaces and gesture recognition technology to provide hands-free control solutions that may redefine how users interact with consumer electronics and smart environments. Recent developments from the company highlight both growing market demand and Wearable Devices’ strategic role in unlocking new use cases for touchless wearable technology.

An already approved cancer drug called Carfilzomib may help restore the effectiveness of CAR-T cell therapy in advanced multiple myeloma cases. Technical University of Munich researchers have discovered a molecular mechanism that causes cancer cells to evade treatment and have shown that blocking it can make immunotherapy work again in some patients.

AI-powered drones are changing the way people watch the Winter Olympics. At the 2026 Winter Games in Milan-Cortina, new technology is being used to make sports broadcasts more exciting, clear, and immersive. Olympic Broadcasting Services (OBS), the organization responsible for filming and sharing the Games with the world, has expanded the use of drones and artificial intelligence to improve the viewing experience.

SOLOWIN HOLDINGS (NASDAQ: AXG) subsidiary AlloyX Limited announced a strategic partnership with Bahrain FinTech Bay to drive innovation and accelerate adoption of regulated stablecoin applications, further strengthening Bahrain’s position as a regional hub for digital finance. Under the collaboration, AlloyX will work within Bahrain FinTech Bay’s innovation ecosystem alongside global and regional payments and technology partners to explore next-generation stablecoin application scenarios, as it advances plans toward regulatory approval and the subsequent market launch of its stablecoin. Leadership said the partnership aligns with its vision to build compliant and scalable stablecoin solutions in Bahrain, delivering benefits for the GCC region and global markets.

Recent weeks have seen gold prices swing wildly, and many market participants and analysts have been trying to figure out the forces behind this high volatility that isn’t typical of how the gold market has previously behaved. Major concerns arose after gold climbed to a record price of $5,594 an ounce, only to plummet by almost 10% the following day on Jan. 30. From that day, bullion has experienced very high volatility and it has been a struggle for the metal to stay above the $5,000 per ounce price.

BioMedWire Editorial Coverage: Biotech dealmaking is increasingly defined by a clear strategic shift: Pharmaceutical companies are prioritizing de-risked, late-stage assets with human clinical validation rather than speculative early-stage programs. After years of capital flowing into preclinical platforms with uncertain timelines, investors and acquirers are gravitating toward programs with established safety and efficacy data that can accelerate commercialization pathways. This evolving landscape naturally places companies such as Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ), which holds multiple clinical-stage and late-stage programs across oncology and central nervous system (“CNS”) indications, into focus as strategic assets aligned with current M&A priorities. The company just announced key advancements in its global intellectual property portfolio supporting OT-101, its proprietary TGF-β antisense therapeutic platform. The advancements strengthen protection across neurology, oncology and central nervous system (“CNS”) drug delivery designed to delivery drugs into the brain by getting through the blood brain barrier. This M&A trend bolsters Oncotelic Therapeutics’ position in the oncology and CNS sectors as the OTLC joins other companies focused on the space, including Arrowhead Pharmaceuticals Inc . (NASDAQ: ARWR), MeiraGTx Holdings plc (NASDAQ: MGTX), Supernus Pharmaceuticals Inc. (NASDAQ: SUPN) and…

AINewsWire Editorial Coverage : As artificial intelligence (“AI”) evolves beyond generative chat systems into agentic AI capable of autonomous action, a critical bottleneck has emerged: the lack of high-fidelity, real-time input connecting human intent to machine execution. While AI models can generate text, images or strategies, translating subtle human signals into actionable machine instructions remains a major technical challenge. Without precise and continuous intent capture, autonomous systems — from humanoid robotics to extended reality (“XR”) environments — struggle to operate seamlessly alongside humans. Wearable Devices Ltd. (NASDAQ: WLDS) ( Profile ) aims to address this gap with the launch of ai6 Labs, a synergistic neural AI ecosystem designed to bridge intent and digital reality by integrating research, product monetization and accelerated innovation through technologies such as its Large MUAP Model (“LMM”). The launch positions the AI pioneer as a foundational infrastructure provider for the emerging autonomous AI era and establishes it as an innovator in the space, enabling boosting solutions by other AI leaders, such as Alphabet Inc. (NASDAQ: GOOG), Meta Platforms Inc. (NASDAQ: META), Apple Inc. (NASDAQ: AAPL), NVIDIA Corp. (NASDAQ: NVDA) to the next…

SOLOWIN HOLDINGS (NASDAQ: AXG) subsidiary AlloyX Limited announced a strategic partnership with Bahrain FinTech Bay to drive innovation and accelerate adoption of regulated stablecoin applications, further strengthening Bahrain’s position as a regional hub for digital finance. Under the collaboration, AlloyX will work within Bahrain FinTech Bay’s innovation ecosystem alongside global and regional payments and technology partners to explore next-generation stablecoin application scenarios, as it advances plans toward regulatory approval and the subsequent market launch of its stablecoin. Leadership said the partnership aligns with its vision to build compliant and scalable stablecoin solutions in Bahrain, delivering benefits for the GCC region and global markets.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

Datavault AI (NASDAQ: DVLT) announced that its board of directors has changed the distribution date for its previously announced dividend of warrants to purchase shares of common stock to Feb. 23, 2026, from Feb. 21, 2026, while the record date remains Jan. 7, 2026. The warrants will be issued to eligible record holders on the basis of one warrant for every 60 shares of common stock held, with each warrant exercisable at $5.00 per share for one year from the distribution date. Exercise will require holders to satisfy specified conditions, including holding one Dream Bowl Meme Coin II token per warrant in a Datavault account digital wallet, and will be subject to additional terms, transfer restrictions and potential adjustments as outlined in the warrant agreement and related SEC filings.

Kentucky marijuana officials are urging lawmakers to broaden the list of medical conditions that qualify patients for a medical cannabis card. In a letter sent Thursday to top legislative leaders, the OCM outlined its case for expanding eligibility under the state’s relatively new program.

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.

SEGG Media (NASDAQ: SEGG, LTRYW) announced it has agreed to binding terms to acquire at least a majority interest in Veloce Media Group, valuing Veloce at approximately $61 million (£45 million), with closing expected Feb. 17, 2026. The transaction, to be completed through a combination of cash and SEGG common shares priced at $10 per share, is projected to contribute more than $20 million in additional annual revenue beginning in the first quarter of 2026 and will provide SEGG with a controlling interest for consolidation purposes, as the company positions the acquisition as a foundational step in building a diversified global sports, gaming and digital media platform.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

Disseminated on behalf of Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) and may include paid advertising.

Safe Pro Group (NASDAQ: SPAI), a developer of AI defense and security solutions, recently showcased products from the company’s wholly owned ballistics protection unit, Safe-Pro USA LLC, at SHOT Show 2026 . “The SHOT Show (Shooting, Hunting and Outdoor Trade Show) is an annual event held in Las Vegas that attracts more than 55,000 industry professionals from across the globe… At the show, Safe Pro showcased the company’s latest American-made, high-performance, lightweight, and ultra-thin hard armor plates. These are currently undergoing certification testing by the U.S. Department of Justice for compliance with the latest ballistic standard…The company also debuted the new RAPID series shield. This is a quick-response and lighter-weight law enforcement solution. It is smaller and more mobile than traditional options, which makes it ideal for using in smaller spaces or during high-risk traffic stops.”

A2Z Cust2Mate Solutions (NASDAQ: AZ), a retail technology company, is focused on digitizing the in-store shopping experience through its Cust2Mate smart-cart platform. “The company’s solution retrofits existing shopping carts with interactive hardware and software, enabling in-cart checkout, personalized engagement and data collection,” reads a recent article. “The company’s corporate presentation outlines how this technology is monetized through two primary pillars: a subscription-based smart-cart model and a retail media platform that turns shopping journeys into monetizable digital channels.”

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may include paid advertising.

Wearable Devices (NASDAQ: WLDS) continues to venture into new frontiers with its proprietary neural interface technology, strategically targeting the quickly evolving smart glass and augmented reality market. In a recent announcement, the company made public its collaboration with Rokid, a leading force in human-computer interaction and AR glasses, to deliver seamless, wrist-based gesture control for Rokid’s AI and AR eyewear ( ibn.fm/2mobH ).

Slips announced the close of a $3.5 million series seed round led by Las Olas Capital and Sunset Bay Capital, with participation from strategic investors including Andrew Schwartzberg, to support expansion of its social-first, peer-to-peer betting platform where users compete directly against each other rather than against a sportsbook. The company said proceeds will be used to scale technology, grow its team and accelerate national user acquisition, building on reported 500% year-over-year growth, recent ACH payout integration and continued development of in-real-life betting experiences and expanded financial infrastructure.

Olenox Industries (NASDAQ: OLOX) announced it has entered into a mutual settlement and release agreement with Cedar Advance LLC, resolving outstanding amounts owed under previously executed Standard Merchant Cash Advance Agreements. Under the agreement, executed Feb. 10, 2026, Olenox will issue restricted shares of common stock at market price in satisfaction of the obligations, with both parties agreeing to a full release of claims related to the agreements; full terms of the settlement are disclosed in a Form 8-K filed with the Securities and Exchange Commission on Feb. 13, 2026.

LIXTE Biotechnology Holdings (NASDAQ: LIXT) is entering 2026 with momentum on both scientific and community fronts, announcing progress in its lead oncology program while also sponsoring a major health and wellness summit focused on addressing disparities in care. The company’s announcements highlight advances surrounding LB-100, its first-in-class cancer therapy candidate designed to enhance the effectiveness of existing treatments and underscore its involvement in community health initiatives through its sponsorship of the Good Health: Mind, Body & Soul Summit.

ZeroStack (NASDAQ: ZSTK), an AI-focused asset management company, announced it has earned its first 1 million 0G Tokens in staking rewards since commencing staking activities on Jan. 21, 2026, reflecting an approximate 21% annual percentage yield under current network conditions. Based on an average token price of $0.84 between Jan. 21 and Feb. 2, 2026, the rewards equate to roughly $840,000 for the period, or about $60,000 per day, with approximately 70,000 0G Tokens earned daily. The company said the milestone supports its strategy of deploying capital into yield-generating, AI-focused digital assets, while noting that staking yields are variable and subject to market, protocol, technical and regulatory risks and are not guaranteed to continue at current levels.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Nutex Health (NASDAQ: NUTX) announced the reopening of Bayou City ER & Hospital, a 40,000-square-foot facility in Humble, Texas, northeast of Houston, featuring eight emergency room beds, 46 inpatient beds, a full-service laboratory and advanced imaging capabilities including CT, X-ray and ultrasound. Company leadership said the reopening of its largest hospital strengthens access to 24/7 concierge-level care in the Humble and Kingwood areas and supports expansion of specialized services such as behavioral health and medical detox, reinforcing Nutex’s commitment to delivering high-quality, community-focused healthcare.

Earth Science Tech (OTC: ETST) is redefining the traditional holding company model by building a diversified portfolio designed for long-term sustainability. Unlike passive investment vehicles, ETST takes an active role in its subsidiaries, utilizing hands-on management and disciplined execution to enhance performance across the board.

Chinese copper purchasers are lengthening their Lunar New Year holiday as prices hover near record levels, dampening industrial demand for the red metal. Shanghai Wooray Metals’ General Manager Wang Wei explained that the recent surge has raised financing pressures for copper pipe and rod manufacturers and shrunk their order volumes.

Six years after producing its first battery-electric vehicle, Volkswagen Group has now manufactured its five millionth electric drive unit globally, underscoring the automaker’s rapid expansion in battery-electric vehicle powertrain manufacturing. The milestone reinforces VW’s standing among the world’s largest producers of EV drive systems as electrification accelerates across its brand portfolio.

A groundbreaking study led by a pair of researchers from Israel and involving research teams in several countries has discovered why some forms of breast cancer metastasize into the brain and become deadly. Their findings could open new doors in the management of breast cancer and address the needs of patients who are at a higher risk of developing metastases in the brain.

American tech conglomerate Cisco is tapping solar energy to lower costs and cut greenhouse gas emissions. The firm has locked down a 15-year financial arrangement with R. Power that bankrolls 470 gigawatt hours of fresh solar capacity without physically receiving the electricity. R.Power’s virtual power purchase agreement (VPPA) establishes fixed pricing while developers sell actual power into Poland’s grid. Cisco will receive payments when market rates surpass the contracted price, but will have to cover shortfalls when prices dip below market rates.

Sergey Nazarov, co-founder of Chainlink, believes the current phase of the crypto market is revealing more about the industry’s future than price charts ever could. In his view, the most meaningful developments are happening behind the scenes, in the systems and use cases that support digital assets, rather than in day-to-day trading swings.

The Pentagon is urging artificial intelligence companies to make their AI tools available on the department’s classified and unclassified networks without imposing the same guardrails that the AI firms implement on ordinary users of their tools.

Forward Industries (NASDAQ: FWDI) reported financial and operating results for the fiscal quarter ended Dec. 31, 2025, marking its first full reporting period as a Solana treasury company and highlighting execution of its SOL-focused strategy. The company held 6,962,501 SOL as of quarter end, nearly all staked, generating more than 112,171 SOL in rewards, while revenue increased more than fourfold year over year to $21.4 million, primarily from staking. Results included a $560.2 million loss and $33.0 million impairment on digital assets under U.S. GAAP due to fair value adjustments, contributing to a net loss of $585.6 million, as management emphasized ongoing development of its validator infrastructure, proprietary liquid staking token fwdSOL and automated market maker initiatives to enhance long-term SOL-per-share growth.

Expanding legal access to marijuana for both recreational and medical use may be linked to lower levels of daily opioid consumption among people who inject substances, according to new research led by a scholar at the Boston University School of Public Health.

Disseminated on behalf of Fairchild Gold Corp. (TSX.V: FAIR) (OTCQB: FCHDF) and may include paid advertising.

Roth Capital Partners announced the addition of Jack Terranova as Managing Director, Healthcare Investment Banking, Noah Huehnergarth as Executive Director, Institutional Sales, and Max Masucci as Managing Director and Senior Research Analyst, further strengthening its healthcare platform across investment banking, institutional sales, and equity research. The firm stated the hires enhance its integrated, sector-focused capabilities in life sciences, diagnostics, and therapeutics, supporting capital markets execution, investor connectivity, and strategic growth initiatives, as ROTH has participated in more than 600 healthcare transactions since 2010 totaling over $25 billion in value.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

Xeriant (OTCQB: XERI) recently expanded the role of Brig. Gen. Blaine D. Holt (ret.), signaling a deeper commitment to disciplined innovation and advanced research. An article discussing this reads, “Holt’s appointment to lead Factor X marked the beginning of his formal involvement with Xeriant and expanded his responsibilities beyond advisory into active leadership of the company’s most forward-looking research initiatives. Xeriant recognized that Holt’s experience advising senior military and government leaders brought a critical perspective to the evaluation and development of advanced technologies with both commercial and strategic relevance…From a governance perspective, Holt’s involvement as the operational leader of Factor X reflects Xeriant’s effort to tightly integrate strategic oversight with innovation execution. The company has framed this structure to reduce friction between vision and implementation, ensuring that advanced research efforts remain aligned with long-term corporate objectives… More broadly, Holt’s increasing participation underscores Xeriant’s intent to position itself at the intersection of advanced technology development and practical application.”

Sonim Technologies (NASDAQ: SONM) changed its corporate name to DNA X, Inc. concurrent with its previously announced asset sale to NEXA(R) formerly Social Mobile. The company stated proceeds from the transaction are expected to fund debt retirement and provide working capital for its digital asset management operations, with DNA X, Inc. moving forward as operator of the DNA X digital asset trading platform acquired in December 2025. The company will temporarily retain the Nasdaq trading symbol SONM, with a planned transition to DNAX in the near future.

HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and approvals across the sector. The recognition underscores HeartBeam’s progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity ECG platform designed to capture the heart’s electrical signals from three distinct directions and synthesize them into a 12-lead ECG for arrhythmia assessment.

Annovis Bio (NYSE: ANVS) announced that an independent Data and Safety Monitoring Board has issued a positive recommendation supporting continuation of its ongoing pivotal Phase 3 Alzheimer’s disease clinical trial of buntanetap without modification following a 6-month safety review. The DSMB found no safety concerns after evaluating unmasked data, with safety outcomes in Alzheimer’s patients consistent with those observed in Parkinson’s patients at the same time point, and additional safety reviews planned at 12 and 18 months. The Phase 3 trial (NCT06709014), currently 40% complete and recruiting across the United States, is expected to deliver a symptomatic efficacy readout in early 2027 and a disease-modifying readout in early 2028.

Renewal Fuels (OTC: RNWF) announced the appointment of Dwight Cartwright as Chief Operating Officer and member of its Board of Directors, strengthening leadership as the company advances the Texatron(TM) fusion platform toward commercial deployment. Cartwright brings senior experience across operations, manufacturing, infrastructure development and large-scale, technology-driven organizations, and will oversee day-to-day operations, manufacturing and supply chain readiness, infrastructure buildout, safety and quality systems, and organizational execution. Leadership highlighted his operational discipline and experience scaling complex programs as critical to supporting American Fusion’s next phase of growth and deployment.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

SOLOWIN HOLDINGS (NASDAQ: AXG) announced it has entered into a securities purchase agreement with Streeterville Capital, LLC for up to $100 million in financing through the issuance of one or more pre-paid purchases for AXG class A ordinary shares. The company completed an initial pre-paid purchase of approximately $5.415 million before discounts and expenses, with additional purchases subject to mutual consent. Proceeds are expected to support expansion of AXG’s stablecoin and asset tokenization businesses, advance research and development in artificial intelligence and blockchain security technologies, and fund global market expansion, with further transaction details disclosed in its Form 6-K and Prospectus Supplement on Form 424B5 filed Feb. 9, 2026.

This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) and Sapu Bioscience announced key advancements in their global intellectual property portfolio supporting OT-101, a proprietary TGF-β antisense therapeutic platform, with allowed patent claims in Australia covering OT-101 (SEQ ID NO:9) for the treatment of Parkinson’s Disease, including associated sleep-related symptoms, and granted utility model patents in China and Germany for an intracranial continuous infusion delivery device. The company stated the expanded protection spans therapeutic use claims, CNS delivery methods, device-enabled administration and broader oncology and neurology applications, forming an integrated commercialization platform intended to strengthen long-term defensibility, support strategic partnerships and enhance shareholder value, with additional data presentations planned at BIO-Europe Spring March 23—25, 2026.

SuperCom (NASDAQ: SPCB) announced a new electronic monitoring service provider contract in Louisiana, marking its entry into its 16th new U.S. state and 17th new service provider partnership since mid-2024. Under the agreement, SuperCom will serve as the primary EM technology partner for a Louisiana-based provider operating statewide supervision programs, transitioning existing GPS tracking operations to its proprietary PureSecurity(TM) platform under a recurring revenue model based on daily active units. Management stated the agreement reflects continued competitive incumbent displacement and supports the company’s disciplined U.S. expansion strategy focused on scalable technology deployment and long-term partnership growth.

NanoViricides, Inc. (NYSE American: NNVC) announced it has filed an application for Orphan Drug Designation for NV-387 as a treatment for MPox with the U.S. FDA Office of Orphan Products Development. If granted, the designation would provide incentives including tax credits for qualified clinical trials, exemption from certain user fees and potential seven years of market exclusivity following approval. The company highlighted ongoing global MPox concerns, limited therapeutic options and challenges associated with existing smallpox antivirals such as TPOXX(R) and TEMBEXA(R), noting continued viral mutations and the need for an effective therapeutic solution.

Soligenix (NASDAQ: SNGX) issued a shareholder update from President and CEO Dr. Christopher J. Schaber outlining anticipated 2026 milestones across its late-stage rare disease pipeline, including top-line data from the Phase 3 FLASH2 trial of HyBryte in early-stage cutaneous T-cell lymphoma expected in the second half of 2026, with an interim analysis approaching in the second quarter and 66 of 80 patients enrolled as of Feb. 10. The letter also reviewed positive Phase 2a data for SGX945 (dusquetide) in Behçet’s Disease published in Rheumatology (Oxford), encouraging Phase 2a psoriasis results for SGX302, ongoing strategic evaluations including partnership and M&A opportunities, and the company’s cash position of approximately $10.5 million as of Sept. 30, 2025, with runway projected through 2026.